F. D. De Felice

Physiology · 2007–2019

A researcher in the Science corpus: 5 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom F. D. De Felice trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Mark P. Mattson
  2. D. Selkoe
  3. M. White
  4. Christian Haass
  5. K. Petersen
  6. G. Hotamışlıgil
  7. K. Viola
  8. Ana M Fernandez
  9. V. Samuel
  10. M. Schwartz

Papers from F. D. De Felice's perspective

Ordered by how strongly the researchers F. D. De Felice trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pathways towards and away from Alzheimer's disease (Nature)
  2. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo (Nature)
  3. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. (Journal of Clinical Investigation)
  4. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. (Neurobiology of Aging)
  5. Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* (Journal of Biological Chemistry)
  6. Regulation of NMDA receptor trafficking by amyloid-β (Nature Neuroscience)
  7. Intranasal insulin improves cognition and modulates β-amyloid in early AD (Neurology)
  8. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. (Journal of Clinical Investigation)
  9. Increased risk of type 2 diabetes in Alzheimer disease. (Diabetes)
  10. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. (Behavioural Brain Research)

Their papers